RxDoctor Payments Data

Ross Clevens, MD

Plastic Surgery Within the Head and Neck · Melbourne, FLNPI 1538140231

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $197,792 of the $207,739 with a category attached, or 95.2%. AbbVie accounts for 98.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $74,520 and has fallen 99.6% since, to $334 in 2025. Among plastic surgery within the head and neck clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$207,739in general payments, 2019–2025

Across 254 payments — averaging $817.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$205K
  • Merz North America, Inc.$2K
  • Galderma Laboratories, L.p.$413
  • Zimmer Biomet$123
  • Pacira Pharmaceuticals Incorporated$19
  • Pfizer$12

What the payments were for

  • Consulting fees$2,7501%
  • Speaking & faculty fees$197,79295%
  • Food & beverage$7,1973%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$207,739 in reported general payments places this provider in the 95th percentile of 50 plastic surgery within the head and neck providers in Florida.

See all plastic surgery within the head and neck providers in Florida

Medicare billing

Part B allowed, 2024
$441,295
Medicare patients
304
Services billed
2,204

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tobramycin-DexamethasoneTobramycin/Dexamethasone23$1,025
ValacyclovirValacyclovir Hcl43$464
Cephalexin69$237
Cefadroxil24$213
Doxycycline Hyclate16$82
Promethazine Hcl26$52

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head and neck in Melbourne

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →